» Articles » PMID: 26825910

Large HDL Subfraction But Not HDL-C Is Closely Linked With Risk Factors, Coronary Severity and Outcomes in a Cohort of Nontreated Patients With Stable Coronary Artery Disease: A Prospective Observational Study

Overview
Specialty General Medicine
Date 2016 Jan 31
PMID 26825910
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

High-density lipoprotein (HDL) is highly heterogeneous in its size and composition. Till now, the link of HDL subfractions to coronary risk is less clear. We aimed to investigate the associations of HDL subfractions with traditional risk factors (RFs), coronary severity, and outcomes in a cohort of nontreated patients with stable coronary artery disease (CAD). We prospectively enrolled 591 eligible patients. Baseline HDL subfractions were separated by Lipoprint system. HDL subfractions (large, medium, and small) and HDL-cholesterol (HDL-C) levels were dichotomized into low and high group according to the 50 percentile. Coronary severity was evaluated by SYNTAX, Gensini, and Jeopardy scoring systems. Patients were followed up annually for major adverse cardiovascular events (MACEs). Cox proportional hazards' models were used to evaluate the risk of HDL subfractions on MACEs. Patients with high large HDL-C levels had a decreased number of RFs. Significantly, large HDL-C levels were negatively associated with coronary severity assessed by SYNTAX and Gensini score (both P < 0.05). New MACEs occurred in 67 (11.6%) patients during a median 17.0 months follow-up. Moreover, the log-rank test revealed that there was a significant difference between high and low large HDL-C groups in event-free survival analysis (P = 0.013), but no differences were observed in total HDL-C groups and medium or small HDL-C groups (both P > 0.05). In particular, the multivariate Cox-proportional hazards model revealed that high large HDL-C was associated with lower MACEs risk (hazard ratio [95% confidence interval] 0.531 [0.295-0.959]) independent of potential confounders. Higher large HDL-C but not medium, small, or total HDL-C is associated with lower cardiovascular risk, highlighting the potential beneficial of HDL subfractionation.

Citing Articles

Relationship of high-density lipoprotein subfractions and apolipoprotein A-I with fat in the pancreas.

Liu Y, Shamaitijiang X, Skudder-Hill L, Kimita W, Sequeira-Bisson I, Petrov M Diabetes Obes Metab. 2024; 27(1):123-133.

PMID: 39377129 PMC: 11618224. DOI: 10.1111/dom.15990.


Review of Laboratory Methods to Determine HDL and LDL Subclasses and Their Clinical Importance.

Chary A, Hedayati M Rev Cardiovasc Med. 2024; 23(4):147.

PMID: 39076233 PMC: 11273998. DOI: 10.31083/j.rcm2304147.


HDL-Cholesterol Subfraction Dimensional Distribution Is Associated with Cardiovascular Disease Risk and Is Predicted by Visceral Adiposity and Dietary Lipid Intake in Women.

Sergi D, Sanz J, Trentini A, Bonaccorsi G, Angelini S, Castaldo F Nutrients. 2024; 16(10).

PMID: 38794763 PMC: 11124017. DOI: 10.3390/nu16101525.


Association Between HDL2-C and HDL3-C with Cardiovascular Disease: A Nested Case-Control Study in an Iranian Population.

Chary A, Tohidi M, Hasheminia M, Golmohammadi M, Haji Hosseini R, Hedayati M Int J Endocrinol Metab. 2024; 22(1):e141550.

PMID: 38665147 PMC: 11041996. DOI: 10.5812/ijem-141550.


Postprandial lipid and vascular responses following consumption of a commercially-relevant interesterified palmitic acid-rich spread in comparison to functionally-equivalent non-interesterified spread and spreadable butter: a randomised controlled....

Hall W, Alkoblan A, Gibson P, DAnnibale M, Coekaerts A, Bauer M Food Funct. 2024; 15(5):2733-2750.

PMID: 38380649 PMC: 10911404. DOI: 10.1039/d3fo05324e.


References
1.
Zhang Y, Xu R, Li S, Zhu C, Guo Y, Sun J . Lipoprotein subfractions partly mediate the association between serum uric acid and coronary artery disease. Clin Chim Acta. 2015; 441:109-14. DOI: 10.1016/j.cca.2014.12.030. View

2.
Rosenson R, Brewer Jr H, Chapman M, Fazio S, Hussain M, Kontush A . HDL measures, particle heterogeneity, proposed nomenclature, and relation to atherosclerotic cardiovascular events. Clin Chem. 2011; 57(3):392-410. DOI: 10.1373/clinchem.2010.155333. View

3.
Yadav M, Palmerini T, Caixeta A, Madhavan M, Sanidas E, Kirtane A . Prediction of coronary risk by SYNTAX and derived scores: synergy between percutaneous coronary intervention with taxus and cardiac surgery. J Am Coll Cardiol. 2013; 62(14):1219-1230. DOI: 10.1016/j.jacc.2013.06.047. View

4.
Blacher J, Evans A, Arveiler D, Amouyel P, Ferrieres J, Bingham A . Residual cardiovascular risk in treated hypertension and hyperlipidaemia: the PRIME Study. J Hum Hypertens. 2009; 24(1):19-26. DOI: 10.1038/jhh.2009.34. View

5.
Xu R, Li S, Zhang Y, Li X, Guo Y, Zhu C . Relation of plasma PCSK9 levels to lipoprotein subfractions in patients with stable coronary artery disease. Lipids Health Dis. 2014; 13:188. PMC: 4292809. DOI: 10.1186/1476-511X-13-188. View